Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Godavari Drugs Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 295.52 | 1567.12 |
| Expenses | N/A | N/A |
| PBT | 9.22 | 69.22 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 7.67 | 55.49 |
About Godavari Drugs Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Mukund Kakani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,47,032.09 | 1,863.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,83,758.68 | 6,947.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,223.98 | 4,417.65 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,692.75 | 8,113.50 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,214.23 | 1,434.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,08,739.11 | 1,302.80 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,230.20 | 2,255.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,02,166.27 | 1,052.50 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,01,634.21 | 2,457.60 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 99,747.98 | 991.30 | 835.50 - 835.50 |
No Records Found
Latest News
Godavari Drugs informs about certificate
Godavari Drugs has informed that it enclosed certificate issued by CIL Securities, Registrar and Share transfer Agent dated 07th April, 2026 confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Godavari Drugs informs about trading window closure
Godavari Drugs informs about disclosures
Akums Drugs and Pharmaceuticals informs about disruption in operations
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January, 2026, Akums Drugs and Pharmaceuticals has informed that certain manufacturing sites at Haridwar have been impacted due to labour unrest at SIDCUL industrial area in Haridwar on 14th May, 2026. The unrest has resulted in temporarily disruption of operations and active measures are being taken to normalize the operations. Further updates and assessment of the impact will be informed in due course. Management and the local authorities are in discussions with the workers to resolve the issue quickly & amicably.
The above information is a part of company’s filings submitted to BSE.
Yatharth Hospital & Trauma Care Services informs about voting results and scrutinizer report
In furtherance to its notice dated April 09, 2026 regarding the Postal Ballot by the Company, seeking approval of shareholders by means of special resolution through remote E-voting, to approve the creation of security by way of charge/ mortgage/hypothecation and/or otherwise pursuant to section 180(1)(a) of the companies act, 2013, Yatharth Hospital & Trauma Care Services has informed that the members of the Company have approved the resolution as stated in the Postal Ballot Notice, with requisite majority. The company has enclosed the declaration of the results of Postal Ballot made by the Company, including the voting results in the prescribed format under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Also, it has enclosed the Scrutinizer’s Report dated May 14, 2026, issued by Saurav Upadhyay, Practicing Company Secretary. This disclosure will also be hosted on Company's website:https://www.yatharthhospitals.com/investors/corporate-announcements.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Godavari Drugs Ltd. is ₹127.00 as of 2026-05-14.
The market capitalisation of Godavari Drugs Ltd. is ₹128.62 as of 2026-05-14.
The 1-year return of Godavari Drugs Ltd. is 33.02% as of 2026-05-14.
The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-05-15.
The 52-week high and low of Godavari Drugs Ltd. are ₹134.50 and ₹69.70, respectively, as of 2026-05-14.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
